CD8A and cancer: In nonlymphoid organs where off-target tissue damage can have devastating effects (e.g., brain), IL-21 may help guide CD8 T cells toward a mixed TRM-TEX differentiation state and improve immunotherapy outcomes for chronic infections and cancer.